1. Percutaneous Coronary Intervention Versus Medical Therapy for Chronic Total Occlusion of Coronary Arteries: A Systematic Review and Meta-Analysis

   • Ka Hou Christien Li
   • Ka Hei Gabriel Wong
   • Vassilios S. Vassiliou

   Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor) Open access 09 August 2019 Article: 42

   

2. Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence

   • Matthew M. Y. Lee
   • Naveed Sattar
   • Chris J. Packard

   Statin Drugs (M. Tikkanen, Section Editor) Open access 27 July 2019 Article: 41

   

3. PCSK9 Inhibition: New Treatment Options and Perspectives to Lower Atherogenic Lipoprotein Particles and Cardiovascular Risk

   • Julia Brandts
   • Dirk Müller-Wieland

   Nonstatin Drugs (R. Carmena, Section Editor) 27 July 2019 Article: 40

4. Subclinical Cerebrovascular Disease: Epidemiology and Treatment

   • Adam de Havenon
   • Chelsea Meyer
   • Lee Chung

   Cardiovascular Disease and Stroke (S. Prabhakaran, Section Editor) 27 July 2019 Article: 39

   

5. Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis

   • Sanjiv Singh
   • Avtar Singh Gautam

   Evidence-Based Medicine (L. Roever, Section Editor) 27 July 2019 Article: 38

   

6. Looking at Lp(a) and Related Cardiovascular Risk: from Scientific Evidence and Clinical Practice

   • Thomas M. Stulnig
   • Claudia Morozzi
   • Claudia Stefanutti

   Evidence-Based Medicine (L. Roever, Section Editor) 27 July 2019 Article: 37